Lipomatosis, Multiple Symmetrical
Lipomatosis, Multiple Symmetrical
Explore linked clinical trials. Standard reference: MESH:M00125741 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL) | Lipid Metabolism Disorders, Lipomatosis, Multiple Symmetrical, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, lipomatosis, metabolic disease, skin disorder | Active, not recruiting | Phase 2 | 2025-06-12 | NCT05351164 |